Tilray Brands Inc
TLRY: XTSE (CAN)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|.$$b!^z | LOCK|KN | LOCK|>?b@F#$ |
Tilray Earnings: Cannabis Margins Recover, but Canadian Market Remains Extremely Challenging
Tilray reported fiscal third-quarter 2025 earnings, with net revenue declining 1% year over year to $186 million. However, excluding the effect of currency, net revenue would have grown 2%. Adjusted EBITDA margins declined about 60 basis points to 4.8%.
